Biden Administration's Plan to Lower Nicotine in Cigarettes Denounced

Feb.08
Biden Administration's Plan to Lower Nicotine in Cigarettes Denounced
Biden administration pushes plan to reduce nicotine levels in cigarettes, sparking concerns of increased smoking rates and organized crime.

According to a report from the NY Post on January 7th, the Biden administration is advancing a plan to reduce the nicotine content in cigarettes during the final stages of Biden's presidency. Critics argue that this could potentially lead to increased smoking among Americans and fuel organized crime groups.


The Food and Drug Administration (FDA) announced last week that they have just completed a regulatory review of the proposed rule "Standards for Tobacco Products with Reduced Nicotine Content" in the Office of Management and Budget's ROCIS system, showing that the review was completed on January 3rd.


According to reports, the plan claims to aim at reducing the addictiveness of cigarettes for casual users. However, opponents believe that this change could lead to existing smokers using more cigarettes to compensate for the reduced nicotine content, and could potentially open up opportunities for black market sales of standard nicotine content cigarettes.


Rich Marianos, former Assistant Director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, stated in an interview with Fox News that the ban is essentially a "gift" to organized crime groups, which will only lead to increased smoking and exacerbate street violence among Americans.


It is currently unclear whether the FDA will release proposed rules regarding the regulation before Biden leaves office on January 20. The plan was announced for 2022, with formal proposed rules expected in 2023, but the reasons for the delay are unknown. Similarly, progress on the FDA's ban on mint-flavored cigarettes has also been slow.


Once the draft rules are proposed, they will enter the public notice and comment phase, where supporters and opponents will present their arguments before a final decision is made. This process is likely to impact the government of President-elect Donald Trump, with the final decision being controlled by relevant officials nominated by the Republican Party, such as Health and Human Services Secretary nominee Robert F. Kennedy Jr. and FDA Commissioner nominee Marty Makary.


FDA director Robert Califf stated in 2022 that the program will help current smokers as well as future potential smokers. Many cigarette users have already switched to other nicotine delivery options considered to be lower risk, such as e-cigarettes and smokeless tobacco.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.